Fast Five Quiz: Systemic Treatments for Plaque Psoriasis

Chris G. Adigun, MD


May 21, 2020

Approximately 125 million people around the world are affected by psoriasis, a chronic, relapsing inflammatory skin disorder. Several clinical variants of psoriasis are recognized, but plaque psoriasis is the most common. Psoriasis is associated with a significantly increased risk for inflammatory comorbidities, including psoriatic arthritis, depression, obesity, diabetes, liver disease, metabolic syndrome, and cardiovascular disease. Patients with moderate to severe psoriasis are often undertreated and report disappointment with treatment, poorly managed symptoms, and sustained effect of the disease on quality of life. A variety of systemic therapies are available, however, which have been shown to be more effective in reducing clinical symptoms, achieving treatment efficacy targets, and improving quality of life. 

How much do you know about systemic treatments for plaque psoriasis? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: